BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · Registration

AERAS

4th Quarter (Oct 1 - Dec 31) · 2013Posted Jan 16, 2014Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: AERAS
Description: Nonprofit BioTech Company Advancing Vaccine Science for Tuberculosis
Location: Maryland · United States of America

Registrant

Firm: MWW GROUP
Description: Lobbying and Government Relations
Location: New York, New York, United States of America

Lobbying activities

4 issues

Health Issues
Funding Support for Tuberculosis Vaccine Research
LobbyistsRYAN HAAKER
Foreign Relations
Funding Support for Tuberculosis Vaccine Research
LobbyistsRYAN HAAKER
Budget/Appropriations
Funding Support for Tuberculosis Vaccine Research
LobbyistsRYAN HAAKER
Medical/Disease Research/Clinical Labs
Funding Support for Tuberculosis Vaccine Research
LobbyistsRYAN HAAKER

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

AERAS — Lobbying — Receipts Report